Spanish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Pharma Mar

Market Cap: €1.3b

A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Labiana Health

Market Cap: €20.7m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

Oryzon Genomics

Market Cap: €177.0m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.